Changes in biotech companies market capitalization in the U.S. 2012-2016
This statistic displays the top 10 changes in market capitalizations of biotechnology companies in the United States between 2012 and 2016. During this period, Amgen had an increase in market capitalization of nearly 58 billion U.S. dollars. Revenues of the United States biotechnology market has grown over the last 15 years.